PDUFA First: Fees To Support US FDA Device Center Staff

To enhance combination product reviews, drug-fee revenue will pay for related positions in the agency's Center for Devices and Radiological Health.

Drug user-fees will support staff in US FDA's device center for the first time beginning in fiscal year 2018.

The move does not stem from altruism by pharmaceutical sponsors and FDA signing on to the PDUFA VI agreement. Rather,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

Already a subscriber?